MetaCap

Senseonics (SENS) vs Shoulder Innovations (SI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Senseonics (SENS) has outperformed Shoulder Innovations (SI) over the past year, gaining 49.9% versus a gain of 37.2%. Senseonics is the larger company by market cap ($439.3 million vs $421.6 million), about 1.0 times the size. Shoulder Innovations converts more of its revenue into profit, with a net margin of -85.3% versus -196.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SENS+49.91%SI+37.17%
+110%+44%-23%
Nov 21, 20251 yearNov 20, 2026
SENS-18.00%SI+41.40%
+65%+5%-56%
Jul 28, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SENS versus SI key metrics
MetricSENSSI
Share price$8.02$20.15
Market cap$439.34M$421.58M
1-day change-9.94%-0.79%
YTD return+45.29%+40.91%
1-year return+49.91%+37.17%
5-year return-87.59%—
P/E ratio (TTM)—17.99
EPS (TTM)$-2.27$1.12
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$35.26M$47.32M
Revenue growth (YoY)+56.89%+49.63%
Net income (latest FY)$-69.10M$-40.36M
Gross margin44.71%76.51%
Operating margin-193.83%-55.58%
Net margin-195.99%-85.29%
52-week high$13.98$24.60
52-week low$4.79$12.00
Distance from 52-week high-42.62%-18.07%
Analyst consensusbuystrong_buy
Avg. price target upside+88.03%+34.00%
Average volume821.73K120.15K
Shares outstanding54.78M20.92M
Employees130—
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SENS has outperformed SI by 12.7 percentage points over the past year.
  • Shoulder Innovations is more profitable, keeping -85.3 cents of every revenue dollar as net income versus -196.0 cents for Senseonics.
  • Senseonics grew revenue faster in its latest fiscal year (+56.89% vs +49.63%).

About Senseonics

SENS stock →

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.

Health Care · Medical/Dental Instruments · 130 employees

SENS vs SI FAQ

Which is bigger, Senseonics or Shoulder Innovations?

Senseonics (SENS) is larger, with a market capitalization of $439.34M compared with $421.58M for Shoulder Innovations (SI).

Which stock has performed better over the past year, SENS or SI?

SENS returned +49.91% over the past 12 months, compared with +37.17% for SI (price return, excluding dividends). Past performance does not predict future results.

Are Senseonics and Shoulder Innovations in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons